A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Cefonicid
Hydrotalcite
Hydrotalcite can cause a decrease in the absorption of Ledipasvir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cefonicid
Aluminium acetoacetate
Aluminium acetoacetate can cause a decrease in the absorption of Ledipasvir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cefonicid
Magnesium silicate
Magnesium silicate can cause a decrease in the absorption of Ledipasvir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cefonicid
Bismuth subnitrate
Bismuth subnitrate can cause a decrease in the absorption of Ledipasvir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cefonicid
Magnesium carbonate
Magnesium carbonate can cause a decrease in the absorption of Ledipasvir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cefonicid
Magnesium trisilicate
Magnesium trisilicate can cause a decrease in the absorption of Ledipasvir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cefonicid
Magnesium hydroxide
Magnesium hydroxide can cause a decrease in the absorption of Ledipasvir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cefonicid
Magaldrate
Magaldrate can cause a decrease in the absorption of Ledipasvir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cefonicid
Calcium carbonate
Calcium carbonate can cause a decrease in the absorption of Ledipasvir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cefonicid
Aluminum hydroxide
Aluminum hydroxide can cause a decrease in the absorption of Ledipasvir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cefonicid
Magnesium oxide
Magnesium oxide can cause a decrease in the absorption of Ledipasvir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cefonicid
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Ledipasvir.
Cefonicid
Pralsetinib
The serum concentration of Ledipasvir can be increased when it is combined with Pralsetinib.
Cefonicid
Ripretinib
The serum concentration of Ripretinib can be increased when it is combined with Ledipasvir.
Cefonicid
Favipiravir
The serum concentration of Ledipasvir can be increased when it is combined with Favipiravir.
Cefonicid
Lasmiditan
The serum concentration of Ledipasvir can be increased when it is combined with Lasmiditan.
Cefonicid
Istradefylline
The serum concentration of Ledipasvir can be increased when it is combined with Istradefylline.
Cefonicid
Fedratinib
The serum concentration of Ledipasvir can be increased when it is combined with Fedratinib.
Cefonicid
Entrectinib
The serum concentration of Ledipasvir can be increased when it is combined with Entrectinib.
Cefonicid
Methylene blue
The serum concentration of Methylene blue can be increased when it is combined with Ledipasvir.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3